Chemotherapy, AdjuvantAdjuvants, ImmunologicRadiotherapy, AdjuvantBreast NeoplasmsCombined Modality TherapyNeoplasm StagingTamoxifenAdjuvants, PharmaceuticNeoplasm Recurrence, LocalFreund's AdjuvantDisease-Free SurvivalPrognosisAntineoplastic Agents, HormonalFluorouracilAntineoplastic Combined Chemotherapy ProtocolsSurvival AnalysisSurvival RateTreatment OutcomeLevamisoleColonic NeoplasmsAntineoplastic AgentsFollow-Up StudiesPancreatic NeoplasmsReceptors, EstrogenRetrospective StudiesAromatase InhibitorsEarly Detection of CancerLymphatic MetastasisNeoplasm MetastasisLung NeoplasmsNeoplasm InvasivenessAdenocarcinomaRectal NeoplasmsStomach NeoplasmsTumor Markers, BiologicalProstatic NeoplasmsCancer VaccinesMastectomyCyclophosphamideReceptor, erbB-2Colorectal NeoplasmsCarcinomaClinical Trials as TopicOvarian NeoplasmsLymph Node ExcisionNitrilesReceptors, ProgesteroneKaplan-Meier EstimateAntimetabolites, AntineoplasticProspective StudiesNeoplasmsLymph NodesNeoplasms, Hormone-DependentTriazolesNeoadjuvant TherapyGene Expression Regulation, NeoplasticScleral DiseasesPostmenopauseMedical OncologyMelanomaMultivariate AnalysisRandomized Controlled Trials as TopicLeucovorinDrug Administration ScheduleEndometrial NeoplasmsCarcinoma, Non-Small-Cell LungNeoplasm ProteinsRisk AssessmentChemoradiotherapy, AdjuvantCisplatinCarcinoma, Squamous CellTime FactorsMice, NudeAge FactorsDisease ProgressionImmunotherapyDrug Resistance, NeoplasmMethotrexatePredictive Value of TestsSkin NeoplasmsCell Line, TumorRisk FactorsUrinary Bladder NeoplasmsBone NeoplasmsImmunohistochemistryUnited StatesAnthracyclinesUterine Cervical NeoplasmsSEER ProgramLiver NeoplasmsMice, Inbred BALB CMenopauseSurvivorsGene Expression ProfilingQuality of LifeReverse Transcriptase Polymerase Chain ReactionDeoxycytidinePaclitaxelDoxorubicinSemustine